Innocrin Pharmaceuticals Holdings, LLC — Form D
Innocrin Pharmaceuticals Holdings, LLC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-13. The offering totals $13.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-07-13
- Form: D
- Accession: 0001626547-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $6.0M
- Remaining: $7.0M
- Investors: 7
- Date of first sale: 2017-07-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-290642
Issuer
- Name: Innocrin Pharmaceuticals Holdings, LLC
- CIK: 0001626547
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 4505 EMPEROR BOULEVARD, DURHAM, NC, 27703
- Phone: 919-237-9536
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Fred Eshelman | Director | Alexandria, VA |
| Richard Kent | Director | London, X0 |
| Douglas Reed | Director | Durham, NC |
| Robert Edward Schotzinger | Director | Durham, NC |
| S. Edward Torres | Director | Durham, NC |
| Andrew Edward von Eschenbach | Director | Durham, NC |
| Kristopher Edward Wood | Director | Durham, NC |
| Fred Eshelman | Executive Officer | Alexandria, VA |
| Charles Edward Osborne | Executive Officer | Durham, NC |
| William Moore | Director | Mountain View, CA |
| William Moore | Executive Officer | Mountain View, CA |
| Steven Weinstein | Director | Dallas, TX |
| James Rosen | Director | New York, NY |
| Thomas Edward Laundon | Executive Officer | Durham, NC |
| Fred Edward Eshelman | Director | Durham, NC |
Other filings by this issuer (2)
More